CorporateStrategy

SOLABS' approach to serving the life sciences markets is based not only upon reducing the absolute cost of GxP compliance but to convert this investment into real strategic advantages in terms of time to market and best practice development.

There are many 'points of pain' on the road from pharmaceutical discovery to the maximizing of manufacture and distribution. Through its dedication to the GxP environment SOLABS is able to maximize internal corporate knowledge at critical period of a product life cycle. With paper systems learning can be lost through poor knowledge and experience transferal at these interfaces. This wastes time and valuable human resources.

For a pharmaceutical company, quicker implementation means earlier market launch, quick batch/lot cycle and faster revenue generation. SOLABS is able to do this through a focus on, and dedication to, the entire drug development life cycle. Bridging the interfaces, bringing current GxP best practices to bear throughout the organisation and providing consultancy on process flow and document management through a service-based business model and making SOLABS' objectives synonymous with those of our customers.